Group One Trading’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83K Buy
2,500
+1,400
+127% +$2K ﹤0.01% 6943
2025
Q4
$1.72K Sell
1,100
-88,600
-99% -$158K ﹤0.01% 7597
2025
Q3
$186K Buy
89,700
+22,000
+32% +$50.4K ﹤0.01% 4746
2025
Q2
$156K Buy
67,700
+42,400
+168% +$311K ﹤0.01% 4578
2025
Q1
$198K Buy
25,300
+15,700
+164% +$125K ﹤0.01% 4025
2024
Q4
$44.8K Buy
9,600
+8,000
+500% +$41.7K ﹤0.01% 5139
2024
Q3
$8.62K Buy
+1,600
New +$11.4K ﹤0.01% 5666
2023
Q4
Sell
-9,000
Closed -$61.6K 7758
2023
Q3
$61.6K Hold
9,000
﹤0.01% 4888
2023
Q2
$81.7K Buy
+9,000
New +$72.3K ﹤0.01% 4817
2023
Q1
Sell
-9,000
Closed -$57.1K 7535
2022
Q4
$57.1K Buy
+9,000
New +$63.9K ﹤0.01% 4886
2022
Q3
Sell
-45,000
Closed -$398K 7833
2022
Q2
$398K Buy
45,000
+43,000
+2,150% +$320K ﹤0.01% 3638
2022
Q1
$17K Buy
2,000
+100
+5% +$898 ﹤0.01% 6862
2021
Q4
$19K Sell
1,900
-2,200
-54% -$32.6K ﹤0.01% 7005
2021
Q3
$80K Buy
4,100
+2,900
+242% +$56K ﹤0.01% 6126
2021
Q2
$21K Buy
+1,200
New +$16.2K ﹤0.01% 7155

Other funds holding INMB

Group One Trading's INMB Position: Q1 2026 in Review

Group One Trading opened a new position in INmune Bio (INMB) in Q1 2026: 388 shares worth $438. The stake represents ﹤0.01% of the portfolio and ranks #7332 among its holdings. This is a return to the name: Group One Trading previously reported a position in INMB as recently as Q3 2025.

Group One Trading first reported a position in INMB in Q2 2021 and has held it in 14 quarters since. The position peaked at $346K in Q3 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Group One Trading held 388 shares of INmune Bio worth $438 as of Q1 2026.
  • INmune Bio was a new Group One Trading position in Q1 2026.
  • INmune Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7332 holding.
  • Group One Trading first reported a position in INmune Bio in Q2 2021 and has held it in 14 quarters since.
  • Group One Trading's INmune Bio position peaked at $346K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.